Scientific Publications: 2000

  1. SL, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Frankel SS. Human Skin Langerhans Cells Are Targets of Dengue Virus Infection. Nature Medicine 2000; 6:816-820
  2. Mummidi S, Bamshad M, Ahuja SS, Gonzalez E, Feuillet PM, Begum K, Galvis MC, Kosteck V, Valente AJ, Murthy KK, Haro L, Dolan MJ, Allan JS Ahuja SK. Evolution of Human and Non-Human Primate CC Chemokine Receptor 5 Gene and mRNA. J Biol Chem, 2000; 275:18946-18961
  3. Kim J, Yang J, VanCott TC, Lee DJ, Manson KH, Wyand MS, Boyer JD, Ugen KE, Weiner DB. Modulation of Antigen-Specific Humoral Responses in Rhesus Macaques by Using Cytokine cDNAs as DNA Vaccine Adjuvants. J Virol 2000; 74:3427-3429
  4. Whalen CC, Nsubuga P, Okwera A, Johnson JL, Hom DL, Michael NL, Mugerwa RD, Ellner JJ. Impact of Pulmonary Tuberculosis of Survival of HIV-Infected Adults: A Prospective epidemiologic Study in Uganda. AIDS 2000; 14:1219-28
  5. Gorny MK, VanCott TC, Williams C, Revesz K, Zolla-Pazner S. Effects of Oligomerization on the Epitopes of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins. Virology 2000; 267:220-8
  6. Robertson DL, Anderson JP, Bradac JA, Carr JK, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH, McCutchan F, Osmanov S, Peters M, Pieniezek D, Salminen M, Sharp PM, Wolinsky S, Korber B. HIV-1 Nomenclature Proposal. Science 2000; 288:55-57
  7. McKee KT, Jr, Jenkins P, Garner R, Jenkins RA, Nannis ED, Hoffman IF, Schmitz JL, Cohen MS. Features of Urethritis in a Cohort of Male Soldiers. Clin Infectious Dis 2000; 30:736-741
  8. Birx DL, Loomis-Price LD, Aronson N, Brundage J, Davis C, Deyton L, Garner R, Gordin F, Henry D, Holloway W, Kerkering T, Luskin-Hawk R, McNeil J, Michael N, Peirce PF, Poretz D, Ratto Kim S, Renzullo P, Ruiz N, Sitz K, Smith G, Tacket C, Thompson M, Tramont E, Yangeo B, Yarish R, Redfield RR, the rgp160 Phase II Vaccine Investigators. Efficacy Testing of Recombinant Human Immmunodeficiency Virus (HIV) gp160 as a Therapeutic Vaccine in Early-Stage HIV-1-Infected Volunteers. J Infect Dis 2000; 181:881-9
  9. Jagodzinski LL, Wiggins DL, McMannis JL, Emery S, Overbaugh J, Robb M, Bodrug S, Michael N. Use of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 To Assess the Performance of Viral RNA Quantitation Tests. J Clin Microbiol 2000; 38:1247-1249
  10. DeSouza MS, Karnasuta C, Brown A, Markowitz L, Nitayaaphan S, Garner RP, McNeil JG, Birx DL, Cox JH. A Comparative Study of the Impact of HIV Infection on Natural Killer Cell Number and Function in Thais and North Americans. AIDS Res Retroviruses 2000; 16:1061-1066
  11. Sena AC, Miller WC, Hoffman IF, Hakraborty H, Cohen MS, Jenkins P, McKee KT, Jr. Trends of Gonorrhea and Chlamydial Infection During 1985-1996 Among Active Duty Soldiers at a United States Army Installation. Clin Infect Dis 2000; 30:742-8
  12. Jenkins RA, Jenkins PR, Nannis ED, McKee KT, Jr, Temoshok LR. Correlates of Human Immunodeficiency Virus Infection Risk Behavior in Male Attendees of a Clinic for Sexually Transmitted Disease. Clin Infect Dis 2000; 30:723-9
  13. Jenkins PR, Jenkins RA, Nannis ED, McKee KT, Jr, Temoshok LR. Reducing Risk of Sexually Transmitted Disease (STD) and Human Immunodeficiency Virus Infection In A Military STD Clinic: Evaluation of a Randomized Preventative Intervention Trial. Clin Infec Dis 2000;30:730-5
  14. Wegner SA, Brodine SK, Mascola JR, Tasker SA, Shaffer RA, Starkey MJ, Barile A, Martin GJ, Aronson N, Emmons WW, Stephan K, Bloor S, Vingerhoets J, Hertogs K, Larder B. Prevalence of Genotypic and Phenotypic Resistance to Anti-retroviral Drugs in a Cohort of Therapy-naïve Hiv-1 Infected US Military Personnel. AIDS 2000; 14:1009-1015
  15. Darden JM, Polonis VR, DeSouza MS, Chantakulkij S, Brown AE, Birx DL, Pattanapanyasat K. A Flow Cytometric Method For Measuring Neutralization of HIV-1 Subtype B and E Primary Isolates. Cytometry 2000;40:141-150
  16. Riley JL, Schlienger K, Blair PJ, Carreno B, Craighead N, Kim D, Carroll RG, June CH. Modulation of Susceptibility to HIV-1 Infection by the Cytotoxic T Lymphocyte Antigen 4 Costimulatory Molecule. J Exper Med 2000; 191:1987-1997
  17. Raux M, Finkielsztein L, Salmon-Ceron D, Bouchez H, Excler JL, Dulioust E, Grouin JM, Sicard D, Blondeau C. Comparison of the Distribution of IgG and IgA Antibodies in Serum and Various Mucosal Fluids of HIV Type 1-Infected Subjects. AIDS Res Hum Retroviruses 1999;15:1365-1376
  18. Wang CY, Sawyer LSW, Murthy KK, Fang X, Walfield AM, Ye J, Wang JJG, Chen PD, Li ML, Salas MT, Shen M, Gauduin MC, Boyle RW, Koup RA, Montefiori DC, Mascola JR, Koff WC, Hanson CV. Postexposure Immunoprophylaxis of Primary Isolates by an Antibody to HIV Receptor Complex. Proc Natl Acad Sci 1999; 96:10367-10372
  19. Mascola RJ, Steigler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, Lewis MG. Protection of Macaques Against Viral Transmission of a Pathogenic HIV-1/SIV Chimeric Virus by Passive Infusion of Neutralizing Antibodies. Nature Med 2000;6:207-10
  20. Puri A, Riley JL, Kim D, Ritchey DW, Hug P, Jernigan K, Rose P, Blumenthal R, Carroll R. Influenza Virus Upregulates CXCR4 expression in CD4+ Cells. AIDS Res Hum Retroviruses 2000;16:19-25
  21. Nitayaphan S, Khamboonruang C, Sirisophana N, Morgan P, Chiu J, Duliege AM, Chuenchitra C, Supapongse T, Rungruengthanakit K, DeSouza M, Mascola JR, Boggio K, Ratto-Kim S, Markowitz LE, Birx D, Suriyanon V, McNeil JG, Brown AE, Michael RA. A Phase I/II Trial of HIV SF2 gp120/MF59 Vaccine in Seronegative Thais. Vaccine 2000;18:1448-1455.
  22. Russell KL, Carcamo C, Watts DM, Sanchez J, Gotuzzo E, Euler A, Blanco JC, Galeano A, Alava A, Mullins JI, Holmes KK, Carr JK. Emerging Genetic Diversity of HIV-1 in South Africa. AIDS 2000;14:1785-1791
  23. Raux M, Finkielsztein, Salmon-Ceron D, Bouchez H, Excler JL, Dulioust E, Grouin JM, Sicard D, Blondeau C. IgG Subclass Distribution in Serum and Mucosal Fluids of HIV Type 1-infected Subjects. AIDS Res Hum Retrovirus 2000;16:583-594
  24. McCutchan FE, Viputtigul K, De Souza MS, Carr JK, Markowitz LE, Buapunth P, McNeil JG, Robb ML, Nitayaphan S, Birx DL, Brown AE. Diversity of Envelope Glycoprotein from Human Immunodificiency Virus Type 1 of Recent Seroconverters in Thailand. AIDS Res Hum Retrovirus 2000;16:801-805
  25. Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, Van der Auwera G, Coppens S, Vereecken K, Witte KD, Van Rampelbergh R, Kahindo M, Morison L, McCutchan FE, Carr JK, Albert J, Essex M, Goudsmit J, Asjo B, Salminen M, Buve A, Study Group on Heterogeneity of HIV Epidemics in African Cities, van der Groen G. Simplified Strategy for Detection of Recombinant Human Immunodeficiency Virus Type 1 Group M Isolates by gag/env Heteroduplex Mobility Assay. J Virol 2000;74:363-370
  26. Hioe CE, Jones GJ, Rees AD, Ratto-Kim S, Birx DL, Munz C, Goorny MK, Tuen M, Zolla-Pazner Z. Anti-CD4-Binding Domain Antibodies Complexed with HIV Type 1 Glycoprotein 120 Inhibit CD4+ T Cell-Proliferative Responses to Glycoprotein 120. AIDS Res Hum Retrovirus 200;16:898-905
  27. Whalen CC, Nsubuga P, Okwera A, Johnson JL, Hom DL, Micheal NL, Mugerwa R, Ellner JJ. Impact of Pulmonary Tuberculosis on Survival of HIV-Infected Adults A Prospective Epidemiologic Study in Uganda. AIDS 2000; 14:1219-28
  28. Sena AC, Miller WC, Hoffman IF, Chakraborty H, Cohen MS, Jenkins P, McKee KT. Trends of Gonorrhea and Chlamydial Infection During 1985-1996 Among Active-Duty Soldiers at a United States Army Installation. Clin Infect Dis 2000; 30:742-748
  29. Blair PJ, Riley JL, Harlan DM, Abe R, Tadaki DK, Hoffman SC, White L, Francomano T, Perfetto SJ, Kirk AD, June CH. CD40 Ligand (CD154) Triggers a Short-Term CD4+ T Cell Activartion Response that Results in Secretion of Immunomodulatory Cytokines and Apoptosis. J Exp Med 2000; 191:651-660
  30. Chuachoowong R, Shaffer N, VanCott TC, Chaisilwattana P, Siriwasin W, Waranawat N, Vanprapar N, Young NL, Mastro TD, Lambert JS, Robb M. Lack of Association Between Human Immunodeficiency Virus Type 1 Antibody in Cervicovaginal Lavage Fluid and Plasma and Perinatal Transmission, in Thailand. J Infect Dis 2000;181:1957-63
  31. Kim JJ, Yang JS, VanCott TC, Lee DJ, Manson KH, Wyand MS, Boyer JD, Ugen KEWeiner DB. Modulation of Anti-Specific Humoral Responses in Rhesus Macaques by Using Cytokine cDNAs as DNA Vaccine Adjuvants. J Virol 2000;74:3427-3429
  32. Watt G, Kantipong P, DeSouza M, Chanbancherd P, Jongsakul K, Ruangweerayud R, Loomis-Price LD, Polonis V, Myint KS, Birx DL, Brown AE, Krishna S. HIV Suppression During Acute Scrub-Typhus Infection. Lancet 2000; 356:475-79
  33. O'Hagan DT, Ugozzoli M, Barackman J, Singh M, Kazzaz J, Higgins K, VanCott TC, Ott G. Microparticle in MF59, a Potent Adjuvant Combination for a Recombinant Protein Vaccine Against HIV-1. Vaccine 2000;18:1793-1801
  34. Gorny MK, VanCott TC, Williams C, Revesz K, Zolla-Pazner S. Effects of Oligomerization on the Epitopes of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins. Virology 2000;267:220-228
  35. Brown AE, Markowitz L, Nitayaphan S, Morgan P, Sukwit S, Chinaworapong S, Leelasupasri S, Birx D. DTH Responsiveness of HIV-Infected Thai Adults. J Med Assoc Thai 2000; 83:633-639
  36. Chanbancherd P, Brown AE, Polonis VR, Promratana S, Leelasupasri S, Weerachai L, Tasaniyananda C, and deSouza MS. Correlation between CD4 T cell numbaer and anti-p24 antibody titer in HIV-1 subtype E infections. Thai AIDS J 2000;12:206-211
  37. Cleghorn, F., Jack, N., Carr, J., Edwards, J., Mahabir, B., Sill, A., McDanal, C., Connolly, S., Goodman, D., Bennetts, R., O'Brien, T., Weinhold, K., Bartholomew, C., Blattner, W. and Greenberg, M., A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. Proc Natl Acad Sci USA 2000. 97: p10532-10537
  38. Cox, J. and de Souza M., Evaluation of natural killer cell activity. Mol Biotechnol 2000. 15: p147-154
  39. Emery, S., Bodrug, S., Richardson, B., Giachetti, C., Bott, M., Panteleeff, D., Jagodzinski, L., Michael, N., Nduati, R., Bwayo, J., Kreiss, J. and Overbaugh, J., Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000. 38: p2688-2695
  40. Ferrari, G., Kostyu, D., Cox, J., Dawson, D., Flores, J., Weinhold, K. and Osmanov, S., Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines. AIDS Res Hum Retroviruses 2000. 16: p1433-1443
  41. Fiscus, S., Brambilla, D., Coombs, R., Yen-Lieberman, B., Bremer, J., Kovacs, A., Rasheed, S., Vahey, M., Schutzbank, T., Reichelderfer, P. and Group, A., Multicenter evaluation of methods to quantitate human immunodeficiency virus type 1 RNA in seminal plasma. J Clin Microbiol 2000. 38: p2348-2353
  42. Glenn, G., Taylor, D., Li, X., Frankel, S., Montemarano, A. and Alving, C., Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 2000. 6: p1403-1406
  43. Hertogs, K., Bloor, S., De, V. V., van, D. E. C., Dehertogh, P., van, C. A., Sturmer, M., Alcorn, T., Wegner, S., van, H. M., Miller, V. and Larder, B., A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V. Antimicrob Agents Chemother 2000. 44: p568-573
  44. Janssens, W., Laukkanen, T., Salminen, M., Carr, J., Van, d. A. G., Heyndrickx, L., van, d. G. G. and McCutchan, F., HIV-1 subtype H near-full length genome reference strains and analysis of subtype-H-containing inter-subtype recombinants. AIDS 2000. 14: p1533-1543
  45. Janssens, W., Salminen, M., Laukkanen, T., Heyndrickx, L., van, d. A., Colebunders, R., McCutchan, F. and van, d. G. G., Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants. AIDS Res Hum Retroviruses 2000. 16: p1183-1189
  46. Laukkanen, T., Carr, J., Janssens, W., Liitsola, K., Gotte, D., McCutchan, F., Op, d. C. E., Cornelissen, M., Heyndrickx, L., van, d. G. G. and Salminen, M., Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America. Virology 2000. 269: p95-104
  47. McCutchan, F., Understanding the genetic diversity of HIV-1. AIDS 2000. 14 Suppl 3: S31-44
  48. Pattanapanyasat, K., Thepthai, C., Lamchiagdhase, P., Lerdwana, S., Tachavanich, K., Thanomsuk, P., Wanachiwanawin, W., Fucharoen, S. and Darden, J., Lymphocyte subsets and specific T-cell immune response in thalassemia. Cytometry 2000. 42: p11-17
  49. Piyasirisilp, S., McCutchan, F., Carr, J., Sanders-Buell, E., Liu, W., Chen, J., Wagner, R., Wolf, H., Shao, Y., Lai, S., Beyrer, C. and Yu, X., A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 2000. 74: p11286-11295
  50. Russell, K., Carcamo, C., Watts, D., Sanchez, J., Gotuzzo, E., Euler, A., Blanco, J., Galeano, A., Alava, A., Mullins, J., Holmes, K. and Carr, J., Emerging genetic diversity of HIV-1 in South America. AIDS 2000. 14: p1785-1791
  51. Salminen, M., Ehrenberg, P., Mascola, J., Dayhoff, D., Merling, R., Blake, B., Louder, M., Hegerich, S., Polonis, V., Birx, D., Robb, M., McCutchan, F. and Michael, N., Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction. Virology 2000. 278: p103-110
  52. Walter, E., Gilliam, B., Delmar, J., Spooner, K., Morris, J., Aronson, N., Wegner, S., Michael, N. and Jagodzinski, L., Clinical implications of identifying non-B subtypes of human immunodeficiency virus type 1 infection. Clin Infect Dis 2000. 31: p798-802
  53. Vicenzi, E., Ghezzi, S., Brambilla, A., Sheppard, H.W., Lazzarin, A., Poli, G. and Michael, N.L. 2000. CCR2-64I Polymorphism, Syncytium-Inducing HIV Strains, and Disease Progression. J. Infect. Dis. 182:1572-1580.
  54. Brambilla, A., Villa, C., Rizzardi, G., Veglia, F., Ghezzi, S., Lazzarin, A., Cusini, M., Muratori, S., Santagostino, E., Gringeri, A., Louie, L.G., Sheppard, H.W., Poli, G., Michael, N.L., Pantaleo, G., and Vicenzi, E. 2000. Shorter survival of SDF1-3íA/3íA homozygotes linked to CD4+ T-cell decrease in advanced HIV-1 infection. J. Infect. Dis. 182:311-315.
  55. Kar-Roy A, Dong W, Michael N, and Li Y. 2000. Green fluorescence protein as a transcriptional reporter for the long terminal repeats of the human immunodeficiency virus type 1. J Virol Methods 84:127-138.
  56. Ignatius R, Marovich M, Mehlhop E, Villamide L, Mahnke K, Cox W, Isdell F, Frankel SS, Mascola JR, Steinman RM, and M Pope. ìCanarypox induced maturation of dendritic cells is mediated by apoptotic cell death and TNF-a secretionî. JV 2000, 74:11329-38.
  57. Marovich MA, McDowell MA, Thomas EK, and TB Nutman. ìIL-12p70 production in Leishmania major-harboring human dendritic is a CD40/CD40L dependent processî. J Immunology 2000,164: 5858-65.
  58. McCutchan FE. 2000 HIV/AIDS/ in: Tahopson RCA (ed) Molecular Epidemiology of Infectious Diseases pp143-167., Arnold, London.